Sava Medica Limited, a active public limited company, was established on 10 February 2010 in Wadhwan City, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999GJ2010PLC118600. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.91 Cr.
Formerly known as Sava Medica Private Limited. It upholds a compliant status. Its leadership includes Renu Prashant Anjanikar (Director), Suvarna Vinod Jadhav (Director), Vishal Ramchandra Jadhav (Director). Past directors included Roopali Manohar Deshmukh, Rajiv Bedi, Beharam Shavak Pardiwalla. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shed No.508, Gidc 2, Wadhwan City, Gujarat, 363035.
U74999GJ2010PLC118600
118600
10 February 2010
₹10.00 Cr
₹9.91 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Sava Medica Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Renu Prashant Anjanikar | Director | 05 Jul 2016 | Current |
| Suvarna Vinod Jadhav | Director | 06 Nov 2018 | Current |
| Vishal Ramchandra Jadhav | Director | 18 Sep 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Additional Director | 30 May 2012 | Past |
| Pramod Abcsdd | Additional Director | 06 Oct 2012 | Past |
| Pramod Abcsdd | Company Secretary | 28 Mar 2012 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2016 | Past |
| Pramod Abcsdd | Director | 18 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sava Medica Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 39.68% decrease. The company also saw a substantial improvement in profitability, with a 40.2% increase in profit. The company's net worth dipped by a decrease of 1.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sava Medica had a promoter holding of 99.41% and a public holding of 0.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Sava Medica has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sava Medica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sava Medica's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sava Medica Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Sava Medica Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Nikhil Chandrakant Kulkarni was appointed as a Company Secretary was appointed as a Company Secretary on 12 Feb 2020 & has been associated with this company since 5 years 9 months . was recorded as a recent event.
The activity Suvarna Vinod Jadhav was appointed as a Director was appointed as a Director on 06 Nov 2018 & has been associated with this company since 7 years 26 days . was completed.
Renu Prashant Anjanikar was appointed as a Director was appointed as a Director on 05 Jul 2016 & has been associated with this company since 9 years 4 months . was recorded as a recent event.
Vishal Ramchandra Jadhav was appointed as a Director was appointed as a Director on 18 Sep 2012 & has been associated with this company since 13 years 2 months . was recorded as a recent event.
/PRNewswire/ -- SAVA HEALTHCARE LIMITED which specializes in manufacture and marketing of Nasal Sprays and Dry Powder Inhalers (DPI) announced that the Russian....
The CIN of Sava Medica Limited is U74999GJ2010PLC118600.
Sava Medica Limited is headquartered at Shed No.508, Gidc 2, Wadhwan City, Gujarat, 363035.
Sava Medica Limited was incorporated on 10 February 2010.
The current directors of Sava Medica Limited are
The primary industry of Sava Medica Limited is Manufacturing.
Sava Medica Limited is unlisted.
The authorized capital of Sava Medica Limited is ₹10.00 Cr, and the paid-up capital is ₹9.91 Cr.
The compliance status of Sava Medica Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX